RxDoctor Payments Data

Edward Zamrini

Neurology · Salt Lake City, UTNPI 1578587895

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $25,013 of the $34,955 with a category attached, or 71.6%. Eli Lilly accounts for 68.0% of it on its own, with 11 other manufacturers making up the rest.

$34,955in general payments, 2019–2025

Across 77 payments — averaging $453.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$24K
  • Biogen$7K
  • Merck$2K
  • Novartis$644
  • Genentech USA, Inc.$334
  • E.r. Squibb & Sons, L.L.C.$320
  • plus $473 from 6 others
$1,067,803in research payments, 2019–2025

Across 45 payments — averaging $23,729 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$561K
  • Biogen$344K
  • AbbVie$63K
  • E.r. Squibb & Sons, L.L.C.$38K
  • Takeda Pharmaceuticals U.S.A., Inc.$28K
  • Janssen Research & Development, LLC$15K
  • plus $17K from 4 others

What the payments were for

  • Consulting fees$25,01372%
  • Travel & lodging$7,11220%
  • Food & beverage$2,8308%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,955 in reported general payments places this provider in the 85th percentile of 157 neurology providers in Utah.

See all neurology providers in Utah

Other neurology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →